bluuebunny/crossref_metadata_2025 huggingface dataset:
What vascular skills do general surgery trainees need to learn?
Authors: Panagiotopoulou IG , Pilgrim S , Sengupta N , Iype S , Fareed K , Cattle K , Ellis J , Pournaras DJ , Challand C , Hamed M , Varty K
Published: September 2014

Vascular surgery has recently been recognised as a full surgical specialty in the UK. Major vascular interventions are centralised into hub units where sufficient volume of cases exists to achieve good outcomes and support training. 1 If no consolidation onto a single site has occurred, clinical networks have formed to provide emergency vascular cover for their catchment area. In local district hospitals, visiting vascular surgeons can run clinics, perform day-case minor elective surgery and offer a vascular opinion. 1 In 2013 the first round of trainee recruitment at ST3 level in vascular surgery, separate from general surgery, was completed. Vascular trainees will do less general surgery and as consultants they will work on a pure vascular rota. 2
The insider’s guide to obtaining a national training number in plastic surgery
Authors: Opel S , Ghani Y , Branford OA
Published: September 2014

Plastic surgery is one of the most competitive surgical specialties in the UK. There is a nationalised recruitment system in place and in 2011 there was a competition ratio of applicants to successful candidates of 10:1, with 177 applicants applying for a final number of 18 posts. 1 In 2012 the corresponding ratio was 17:1, with 166 applicants for 10 posts. 2 With such a high number of applicants for so few ST3 posts, candidates must be aware of the requirements to attain a national training number (NTN) early in their surgical career.
Collage as subjective experience: Transitioning, relinquishing, becoming
Authors: Bell Alison F.
Published: September 2014

Through reflexivity and its intrinsic multiple interpretations of the ‘image’, collage allows one to find the words to express subjective experience. By a practicing artist searching for a method of enquiry through creative practice that seamlessly merges the making and the textual, this article will outline the narrative of a synthesis of the thinking through making and ongoing reflexivity where collage is used as a form of methodology within a practice based Ph.D.
Peacebuilding in Timor-Leste: The risk of unsustainability
Authors: Lopes Paula Duarte
Published: September 2014

Although it is currently recognized that peacebuilding and development aid constitute interlinked dynamics, it is still open to debate if they should be addressed sequentially or simultaneously. This article discusses this relation in terms of UN (United Nations) peace missions. The UN has adopted an inclusive narrative regarding development and peace; however, UN peace missions still reveal an exclusive approach. Timor-Leste demonstrates how this discrepancy between discourse and practice has the potential to undermine both efforts.
Document: Fact and fiction
Authors: Petrovsky Helen
Published: September 2014

In turning to photography the paper explores ways of conveying historical truth. It seems that contemporary art places itself at the very limit of representation in an attempt to remain faithful to historical eventuality. In fact, one is reminded of the type of historical occurrence which can be grasped only through ‘as-if presentations’, to remember the Kantian term. ‘Fiction’, therefore, is no longer opposed to ‘truth’, but becomes its conductor and ally.
Photography at a crossroads: Studio as genealogy, dispositif, spur
Authors: Steiner Shepherd
Published: September 2014

The article focuses on the work of Ian Wallace, Jeff Wall and Rodney Graham, in particular, a notion of the studio that provides both an anchor and departure for the work of all three. This genealogy turns primarily on Wallace’s photo-conceptual work from the 1970s, which establishes the space of the studio as an allegory of painting or the modernist tradition, and as the topological equivalent of the museum and street. Using Wallace’s model of post-studio practice as an analytic, the article unpacks the tensions of Wall’s notion of cinematography, highlighting his mounting hesitations with photography understood on the model of the studio system, as an inside/outside relationship and as the mimesis of painting. Finally, the article puts the notions of studio as genealogy and dispositif to work in order to understand the logic of Graham’s emphasis on the durational art of film.
Das Wort vom Kreuz- und das »Kruzifix-Urteil« des Bundesverfassungsgerichtes
Authors: Steinacker Peter
Published: September 2014

The term »Cross« constitutes the identity of all churches, even the protestant one. If this terrn »Cross« is no more comprehended, the church runs to a crisis of her social representation and her own constitution. The »Kruzifix-Urteil« confirms these signals of a crisis and announces a change in the BRD from a religiously neutral state to a layicistic state
»Homo oeconomicus«
Authors: Nutzinger Hans G.
Published: September 2014

Is it imaginable and convenient to apply the economic pattern of the so called »homo oeconomicus« on extraeconomical spheres? The author examines the question. The attraction of the pattern »homo oeconomicus« is the question of the logic of decision in situations of defiency (rational choice and expense-profit calculations). The author follows the key of the question at the reach and radius in differt spheres of application, for example the analysis of criminality and delinquency. Only in the extension of the social frame situation is an economic reductionism of the social reality and the mutiple ways of human acting avoidable
Hans Joachim Iwands Impulse zu einer christlichen Gesellschaftsethik
Authors: Hoffmann Martin
Published: September 2014

After Second World War Hans Joachim Iwand (1899- 1960) reacts upon the experiences during the time of Nazi-Germany with a conception, which deals in a new way with the questions of political ethics. In this conception Iwand criticized the bipolar and traditional pattem of »State and Church« and explores »Society« as a selfcontained and autonomaus theme for political ethics. It is remarkable to see, how lwands approach to »theologia crucis« and the notions of the term »consciene« are now transformed in an pneumaticological way, that opens the ethic for a conception of public responsibility
The Mise en Valeur of the Gold Mines in the Haut-Niger, 1918–1939
Authors: Luning Sabine , Jansen Jan , Panella Cristiana
Published: September 2014

Cet article porte sur l’orpaillage artisanal pratiqué dans les régions minières anciennes du Bouré et du Bambouk à travers la description des effets des politiques d’optimisation des pratiques d’exploitation aurifère précoloniales mises en place par l’administration coloniale française. Les rouages de l’alternance saisonnière entre agriculture et orpaillage dans la vie sociale de cette région ouest-africaine y sont décrits. L’on analyse ainsi les valeurs sociales et les dynamiques de mobilité imbriquées dans ces activités, avant d’interroger les valeurs et les choix des administrateurs coloniaux qui furent à l’origine de ces politiques économiques. En particulier, les auteurs tâchent à montrer d’une part le décalage d’attribution de valeur entre agriculture et orpaillage au sein des politiques économiques coloniales. D’autre part, ils montrent les démarches de restriction de la mobilité interne par l’administration française dans le but d’assurer les nouvelles mesures des politiques agricoles et minières. Tout en se greffant les politiques minières sur l’organisation sociale préexistante des placers, celles-ci enclenchèrent de représentations inédites d’autochtonie et d’appartenance dans le but d’accroître la production et d’imposer des taxes d’exploitation des placers.
William Faulkner’s “Speech Accepting the Nobel Prize in Literature”: A Language for Ameliorating Atomic Anxiety
Authors: LaVoie Mark
Published: September 2014

In 1950, William Faulkner delivered his “Speech Accepting the Nobel Prize in Literature.” The historic moment was one of high atomic anxiety as the unfriendly relationship between the United States and the Soviet Union intensified and the possibility of nuclear war and the end of humanity increased. Faulkner recognized the anxiety and, through his address, offered a language to help cope with the anxieties of the atomic age. This study examines how through the rhetorical strategies of kairos, decorum, and enactment, Faulkner recast humanism in an atomic age and presented the world with a way of living through atomic fear.
Toward Robust Public Engagement: The Value of Deliberative Discourse for Civil Communication
Authors: Waisanen Don
Published: September 2014

This article explores questions about “civility” in the 2012 election. Through an analysis of media discussions raising the term, four themes are constructed focusing on the limitations of civility discourse. While seeking to preserve the best that civil orientations afford, I argue that adding a deliberative approach to such discourse addresses moments when civil appeals appear to be most limited. This essay finds that working between civil and deliberative constructs provides an instructive perspective for understanding the workings of and possibilities for public discourse during situations when civility rhetoric is typically raised. Relative to civil communication—and associated concepts such as dialogue and advocacy—specific norms, benefits, examples, and implications of a deliberative rhetorical vision are charted for problem-solving, public policy contexts.
Regulation of LINE-1 in mammals
Authors: Bodak Maxime , Yu Jian , Ciaudo Constance
Published: September 2014

Transposable elements (TEs) are mobile DNA elements that represent almost half of the human genome. Transposition of TEs has been implicated as a source of genome evolution and acquisition of new traits but also as an origin of diseases. The activity of these elements is therefore tightly regulated during the life cycle of each individual, and many recent discoveries involved the genetic and epigenetic mechanisms in their control. In this review, we present recent findings in this field of research, focusing on the case of one specific family of TEs: the long-interspersed nuclear elements-1 (LINE-1 or L1). LINE-1 elements are the most representative class of retrotransposons in mammalian genomes. We illustrate how these elements are conserved between mice and humans, and how they are regulated during the life cycle. Additionally, recent advances in genome-wide sequencing approaches allow us not only to better understand the regulation of LINE-1 but also highlight new issues specifically at the bioinformatics level. Therefore, we discuss the state of the art in analyzing such bioinformatics datasets to identify epigenetic regulators of repeated elements in the human genomes.
Predictive value for death and rehospitalization of 30-day postdischarge B-type natriuretic peptide (BNP) in elderly patients with heart failure. Sub-analysis of Italian RED Study
Authors: Di Somma Salvatore , Marino Rossella , Zampini Giorgio , Magrini Laura , Ferri Enrico , Shah Kevin , Clopton Paul , Maisel Alan S.
Published: September 2014

Our aim was to determine if, in elderly heart failure (eHF) patients, serial B-type natriuretic peptide (BNP) assessments obtained during follow-up after hospital discharge could have prognostic utility for death and rehospitalizations. In eHF patients, BNP assessment at hospital discharge has been demonstrated to have a high prognostic value; however, its predictive role for future cardiovascular events in eHF patients, when assessed in the period after discharge, both for the correct timing and cut-off levels, has not been completely elucidated.

This study is a monocentric subanalysis of the Italian RED (Rapid Emergency Department) study. We studied 180 consecutive patients admitted for acute HF through serial BNP assessments: at hospital arrival; at discharge; and at 30, 90, and 180 days follow-up outpatient visit.

Both a BNP >400 pg/mL at 30 days after discharge and the percentage variation of BNP from discharge to 30 days (Δ%BNP), compared with a BNP at discharge >400 pg/mL, showed a higher area under the curve (AUC) and odds ratio (OR) in predicting events [AUC=0.842, p<0.0001; OR 7.9 (3.3–19.0), p<0.001 for 30 days BNP and AUC=0.851, p<0.0001; OR 9.5 (4.065–22.572), p<0.0001 for Δ%BNP compared with AUC=0.638, p<0.002; OR 2.4 (1.1–5.3), p=0.032 for BNP at discharge].

In patients at a high risk for future events, BNP levels assessed 30 days after hospital discharge in the absence of signs and symptoms could be predictive of subsequent hospitalization and death. These patients should be considered for closer monitoring and treatment adjustment.
Physiosemiosis as an Influence of Signs
Authors: Deely John
Published: September 2014

It took most of the 20th century fully to establish semiotics as a thematic study of the role and action of signs not only in human culture and life but also in the whole environment that human animals share with all the other life forms that make up the biosphere of planet earth. In the early 20th century investigators were inclined to restrict the action of signs to the realm of human culture and psychology, consistent with the ideas of modern philosophy that severely separates the world of humans from its surroundings supposed as “unknowable” in itself. This idealistic ne plus ultra was definitively transgressed and shattered by the collegial work of Thomas A. Sebeok, who not only established the framework for a “global semiotics” but also demonstrated unequivocally that the whole world of living things (the “biosphere”) cannot exist independently of the action of signs. As Sebeok put it, “semiosis is coextensive with life”. But there remains even so the further question: “Is life coextensive with semiosis?” For, from the demonstration that semiosis is essential for the existence of life, it does not follow that the existence of life is essential for there to be semiosis. It is this last proposition - wrongly taken by many (or most) proponents of biosemiotics today to be a logical consequent of the conclusion that life in its full extent depends upon semiosis - that I examine here: the probability that semiosis not only surrounds life but pre-existed living things, and indeed shaped the universe so as to make living things possible in the first place.
Trade Liberalization and Productivity Performance: Evidence from the Australian Passenger Motor Vehicle Industry
Authors: Bopage Lionel , Sharma Kishor
Published: September 2014

This paper contributes to the ongoing debate about the effects of trade liberalization on productivity performance of the Australian passenger motor vehicle industry, which has experienced significant liberalization over the years. Our analysis indicates that trade liberalization had a negative impact on productivity growth, at least in the immediate post-liberalization period. Empirical results suggest that economies of scale and tariff protection improve productivity, while industry assistance (such as the local content and duty drawback schemes and production subsidies) retards productivity. Policy implications of these findings are that there are dividends in terms of improved productivity by encouraging economies of scale, providing tariff protection and lowering industry assistance.
Non-equilibrium thermodynamics analysis of transcriptional regulation kinetics
Authors: Hernández-Lemus Enrique , Tovar Hugo , Mejía Carmen
Published: September 2014

Gene expression in eukaryotic cells is an extremely complex and interesting phenomenon whose dynamics are controlled
by a large number of subtle physicochemical processes commonly described by means of gene regulatory networks. Such networks consist in a series of coupled chemical reactions, conformational changes, and other biomolecular processes involving the interaction of the DNA molecule itself with a number of proteins usually called transcription factors as well as enzymes and other components. The kinetics behind the functioning of such gene regulatory networks are largely unknown, though its description in terms of non-equilibrium thermodynamics has been discussed recently. In this work we will derive general kinetic equations for a gene regulatory network from a non-equilibrium thermodynamical description and discuss its use in understanding the free energy constrains imposed in the network structure. We also will discuss explicit expressions for the kinetics of a simple model of gene regulation and show that the kinetic role of mRNA decay during the RNA synthesis stage (or transcription) is somehow limited due to the comparatively low values of decay rates. At the level discussed here, this implies a decoupling of the kinetics of mRNA synthesis and degradation a fact that may become quite useful when modeling gene regulatory networks from experimental data on whole genome gene expression.
The effect of lifestyle change and metformin therapy on serum arylesterase and paraoxonase activity in obese children
Authors: Çayır Atilla , Turan Mehmet İbrahim , Gurbuz Fatih , Kurt Nezahat , Yildirim Abdulkadir
Published: September 2014

Obesity is known to be associated with many diseases in the long and short terms. Elevated oxidative stress contributes to the development of such obesity-related diseases as dyslipidemia, diabetes mellitus and hypertension. Levels of the endogenous antioxidants paraoxonase and arylesterase have been shown to decrease in such diseases. The purpose of this study was to investigate whether or not changes in lifestyle and metformin therapy would affect serum paraoxonase and arylesterase levels.

The study was performed with 25 overweight, 26 obese and 25 morbidly obese patients aged 6–15 years as well as 27 healthy children. Serum paraoxonase (PON1) and arylesterase (ARE) activity levels and total cholesterol, triglyceride, low-density protein, high-density protein, very low-density protein, glucose, aspartate amino transferase and alanine amino transferase levels were measured. Enrolled patients were assessed at initial presentation and again at 6 months. No procedure was performed in the control group, while the overweight, obese and morbidly obese groups were recommended diet and exercise and given metformin therapy (insulin-resistant subjects only).

Serum PON1 activity levels in patients with metabolic syndrome were significantly lower than those in individuals without metabolic syndrome (p<0.05), while lipid concentrations were significantly higher (p<0.05). Metabolic syndrome patients had higher serum glucose, total cholesterol, low-density protein, very low-density protein and triglyceride values compared to those of the control group but significantly lower high-density protein values (p<0.05). No difference was determined between the groups in terms of PON1 and ARE levels following diet and exercise and metformin therapy.

Measurement of PON1 and ARE enzyme levels may be useful in monitoring the effectiveness of treatment aimed at reducing oxidative stress in obese children.
Excitation function of (p, α) nuclear reaction on enriched 67Zn: possibility of production of 64Cu at low energy cyclotron
Authors: Szelecsényi Ferenc , Kovács Zoltán , Nagatsu Kotaro , Zhang Ming-Rong , Suzuki Kazutosi
Published: September 2014

The potential for production of the medically relevant
64Cu has been investigated by proton irradiation of highly
enriched 67Zn targets. The excitation function of the
67Zn(p, α)64Cu a nuclear reaction was
measured by the stacked-foil technique up to 30 MeV. The
prediction of the TALYS code was also compared to the measured cross
section results. Based on the improved database of the
67Zn(p, α)64Cu reaction, thick target
yield as a function of energy was also deduced. Production possibility
of 64Cu is discussed in detail, employing different energy
proton beams and with regards to the 61Cu and
67Cu contamination levels as a function of the target
enrichment level. By using
1 μA beam intensity,
6.3505 h irradiation time and enriched 67Zn
target (64Zn ≤ 0.5%,
66Zn ≤ 9%,
67Zn ≥ 80%,
68Zn ≤ 10% and
70Zn ≤ 0.5%), the expected EOB (End Of
bombardment) yields are 43.66, 88.80 and
156.14 MBq/μA
at 12, 15 and 18 MeV proton energies,
respectively. Application time-frames were also deduced where the
total radio-copper contamination level remains below 1%.
The limit distribution of evolving strategies in financial markets
Authors: Chiarella Carl , Di Guilmi Corrado
Published: September 2014

This paper reconsiders the popular Brock and Hommes [Brock, W. A., and C. H. Hommes. 1997. “A Rational Route to Randomness.”
Crystal structure of dithiocyanatotetra(dimethylformamide)manganese(II), Mn(NCS)2[OCHN(CH3)2]4
Authors: Zhao M.-G. , Shi J.-M. , Wu C.-J.
Published: September 2014

C14H28MnN6O4S2, triclinic, P1 (No. 2), a = 7.27(2) Å, b = 9.55(2) Å, c = 9.68(2) Å, α = 82.12(3)°, β = 68.90(3)°, = 67.61(2)°, V = 580.0 Å3, Z = 1, Rgt(F) = 0.069, wRref(F2) = 0.190, T = 298 K.
The crystal structure of cerium decanickel tetraphosphide, CeNi10P4
Authors: Budnyk S. , Prots Yu. , Kuz’ma Yu. B. , Grin Yu.
Published: September 2014

CeNi10P4, orthorhombic, Pnma (No. 62), a = 9.263(1) Å, b = 3.6654(5) Å, c = 22.092(3) Å, V = 750.1 Å3, Z = 4, Rgt(F) = 0.030, wRref(F2) = 0.068, T = 293 K.
Crystal structure of the 1M-modification of caesium gallium(III) monohydrogen triphosphate, 1M-CsGaHP3O10
Authors: Mi J.-X. , Borrmann H. , Huang Y.-X. , Zhao J.-T. , Kniep R.
Published: September 2014

CsGaHO10P3, monoclinic, P121/n1 (No. 13), a = 8.843(1) Å, b = 4.9523(5) Å, c = 11.084(1) Å, β = 108.793(6)0, V = 459.5 Å3, Z = 2, Rgt(F) = 0.042, wRref(F2) = 0.123, T = 295 K.
Crystal structure of yttrium borosilicide, Y5Si2-xB8 (x = 0.13)
Authors: Roger J. , Jardin R. , Babizhetskyy V. , Députier S. , Bauer J. , Guérin R.
Published: September 2014

B8Si1.87Y5, tetragonal, P4/mbm (No. 127), a = 7.2234(2) Å, c = 8.0961(3) Å, V = 422.4 Å3, Z = 2, Rgt(F) = 0.040, wRref(F2) = 0.095, T = 293 K.
Crystal structure of [1R,7,7-trimethylbicyclo[2.2.1]heptan-2,3-bis(2,6- diisopropylphen-1-yl)imine]nickeldibromide]—toluene (1:1), C34H48Br2N2Ni · C7H8
Authors: Amort Ch. , Bildstein B. , Wurst K.
Published: September 2014

C41H56Br2N2Ni, orthorhombic, P212121 (No. 19), a = 10.121(2) Å, b = 17.115(2) Å, c = 22.835(2) Å, V = 3955.5 Å3, Z = 4, Rgt(F) = 0.037, wRref(F2) = 0.086, T = 218 K.
Crystal structure of N-(2,2-dimethoxyethyl)-N'-(trifluoroacetyl)-phenylalanyl- dehydrophenylalaninamide hydrate, C24H26N3O5F3 · H2O, a precursor of intramolecular double cyclization into imidazolopyrazinone
Authors: Tinant B. , Devillers I. , Rees J.-F. , Marchand-Brynaert J.
Published: September 2014

C24H28F3N3O6, monoclinic, P121/c1 (No. 14), a = 9.677(4) Å, b = 11.005(5) Å, c = 24.858(7) Å, β = 92.120, V = 2645.5 Å3, Z = 4, Rgt(F) = 0.064, wRref(F2) = 0.199, T = 293 K.
Crystal structure of pentakispiperidyltantal(V), Ta(NC5H10)5
Authors: Engering J. , Peters E.-M. , Jansen M.
Published: September 2014

C25H50N5Ta, monoclinic, P121/c1 (No. 14), a = 15.3542(9) Å, b = 9.9150(6) Å, c = 18.141(1) Å, β = 108.109(1)°, V = 2624.9 Å3, Z = 4, Rgt(F) = 0.053, wRref(F2) = 0.142, T = 100 K.
Crystal structure of di(2,2′-bipyridine)di[µ-(2,3-dimethoxylbenzoato-O,O′)]- di[µ-2,3-dimethoxylbenzoato-O,O′:O′]di(2,3-dimethoxybenzoato)]- dineodymium(III), Nd2(C9H9O4)6(C10H8N2)2
Authors: Li X. , Zou Y.-Q.
Published: September 2014

C37H35N2NdO12, triclinic, P1 (No. 2), a = 10.9793(5) Å, b = 12.0965(5) Å, c = 15.3714(9) Å, α = 67.072(1)°, β = 83.799(2)°,γ = 72.887(2)°, V = 1796.9 Å3, Z = 2, Rgt(F) = 0.037, wRref(F2) = 0.058, T = 293 K.
Crystal structure of 1-[[(Z)-1-chloroethylidene]-amino]-ethaneiminium chloride, [CH3ClNCNH2CH3]Cl
Authors: Noll Andrea , Müller Ulrich
Published: September 2014

C4H8Cl2N2, orthorhombic, P212121 (No. 19), a = 4.828(2) Å, b = 10.497(3) Å, c = 14.830(4) Å, V = 751.6 Å3, Z = 4, Rgt(F) = 0.052, wRref(F2) = 0.132, T = 193 K.
Crystal structure of (1E,3E)-4-methylthio-2-nitro-3-phenylsulfonyl-1- pyrrolidino-1,3-butadiene, C15H18N2O4S2
Authors: Bianchi L. , Fossa P. , Maccagno M. , Mugnoli A. , Petrillo G. , Tavani C.
Published: September 2014

C15H18N2O4S2, monoclinic, P121/c1 (No. 14), a = 8.754(3) Å, b = 12.499(2) Å, c = 15.599(3) Å, β = 95.09(2)°, V = 1700.1Å3, Z = 4, Rgt(F) = 0.049, wRref(F2) = 0.128, T = 294 K.
Crystal structure of dipimelato-bis(1,10-phenanthroline-N,N′)dilead(II) monohydrate, Pb2(C12H8N2)2(C7H10O4)2 · H2O
Authors: Zheng Y.-Q. , Kong Z.-P. , Chen K.
Published: September 2014

C19H20N2O5Pb, triclinic, P1 (No. 2), a = 7.488(2) Å, b = 11.543(2) Å, c = 11.742(2) Å, α = 83.50(3)°, β = 82.54(3)°, γ = 81.94(3)°, V = 991.7 Å3, Z = 2, Rgt(F) = 0.046, wRref(F2) = 0.128, T = 293 K.
Crystal structure of diaqua(2,2′-bipyridine-N,N′)sulfatomanganese(II) monohydrate, Mn(H2O)2(C10H8N2)(SO4) · H2O
Authors: Zheng Y.-Q. , Lin J.-L.
Published: September 2014

C10H14MnN2O7S, monoclinic, P121/c1 (No. 14), a = 20.924(3) Å, b = 6.667(2) Å, c = 20.107(2) Å, β = 95.21(1)°, V = 2793.4 Å3, Z = 8, Rgt(F) = 0.047, wRref(F2) = 0.107, T = 293 K.
Crystal structure of tetraaquamonosuberatonickel(II), Ni(H2O)4(C8H12O4)
Authors: Zhang B.-S. , Zheng Y.-Q.
Published: September 2014

C8H20NiO8, triclinic, P1 (No. 2), a = 4.874(1) Å, b = 6.329(1) Å, c = 10.560(1) Å, α = 76.78(1)°, β = 87.79(1)°, γ = 76.97(1)°, V = 308.9 Å3, Z = 2, Rgt(F) = 0.024, wRref(F2) = 0.065, T = 293 K.
Crystal structure of 2,5-dimethylanilinium cyclohexaphosphate octahydrate, (C8H12N)6O18P6 · 8H2O
Authors: Khedhiri L.
Published: September 2014

C48H88N6O26P6, triclinic, P1 (No. 2), a = 10.759(3) Å, b = 10.351(9) Å, c = 15.914(6) Å, α = 99.82(6)°, β = 98.02(2)°, γ = 75.96(5)°, V = 1685.2 Å3, Z = 1, Rgt(F) = 0.060, wRref(F) = 0.060, T = 296 K.
Crystal structure of (1-cyclopropyl-6-fluoro-7-chloro-1,4-dihydro- 4-oxo-3-quinolinecarboxylato)chloro(2,2′-bipyridine)copper(II) dihydrate, CuCl(C10H8N2)(C13H8NClFO3) · 2H2O
Authors: Xie L.-M. , Wang G.-P. , He H.-Y. , Zhu L.-G.
Published: September 2014

C23H20Cl2CuFN3O5, triclinic, P1 (No. 2), a = 10.329(2) Å, b = 11.417(4) Å, c = 10.225(3) Å, α = 95.77(3)°, β = 99.10(2)°, γ = 98.65(2)°, V= 1167.5 Å3, Z= 2, Rgt(F) = 0.050, wRobs(F) = 0.061, T = 293 K.
Crystal structure of 1,2-diaminopropanesilver(I) 4-nitrobenzoate dihydrate, Ag(C3H6N2H6)(C7H3NO4) · 2H2O
Authors: Zhu H.-L. , Wang X.-J. , Sun X.-J. , Wang D.-Q.
Published: September 2014

C10H18AgN3O6, triclinic, P1 (No. 2), a = 7.139(2) Å, b = 7.509(2) Å, c = 14.007(4) Å, α = 78.505(5)°, β = 78.789(4)°, γ = 82.023(4)°, V = 717.8 Å3, Z = 2, Rgt(F) = 0.036, wRref(F2) = 0.096, T = 298 K.
Crystal structure of bis[N-(2-(2-hydroxyethylamino)ethyl)salicylideneimine]- cobalt(III) nitrate, C22H30CoN5O7
Authors: Zhu H.-L. , Liu X.-Y. , Wang Y.-F. , Wang D.-Q.
Published: September 2014

C22H30CoN5O7, orthorhombic, Fdd2 (No. 43), a = 18.576(8) Å, b = 56.96(2) Å, c = 9.874(4) Å, V = 10448 Å3, Z = 16, Rgt(F) = 0.057, wRref(F2) = 0.123, T = 298 K.
Crystal structure of dialuminum difluorotetraoxogermanate, Al2GeO4F2
Authors: Mathews M. D. , Tyagi A. K. , Köhler J.
Published: September 2014

Al2F2GeO4, orthorhombic, Pnma (No. 62), a = 8.985(1) Å, b = 8.521(1) Å, c = 4.755(1) Å, V = 364.0 Å3, Z = 4, R(P) = 0.095, R(I) = 0.061, T = 295 K.
Crystal structure of dieuropium trisulfate octahydrate, Eu2(SO4)3 · 8H2O
Authors: Wei D.-Y. , Zheng Y.-Q.
Published: September 2014

Eu2H16O20S3, monoclinic, C12/c1 (No. 15), a = 13.555(2) Å, b = 6.757(1) Å, c = 18.317(2) Å, β = 102.27(1)°, V = 1639.4Å3, Z = 4, Rgt(F) = 0.042, wRref(F2) = 0.105, T = 293 K.
Crystal structure of dekalanthanum tetrabromide pentaaluminide, La10Br4Al5
Authors: Mattausch Hj. , Oeckler O. , Simon A.
Published: September 2014

Al5Br4La10, tetragonal, I4/mcm (No. 140), a = 8.2713(8) Å, c = 32.835(5) Å, V = 2246.4 Å3, Z = 4, Rgt(F) = 0.027, wRref(F2) = 0.058, T = 293 K.
Crystal structure of diaqua-bis[N-(2-pyridyl)carbonylaniline]copper(II) diperchlorate, Cu(C12H16N2O)2(H2O)2(ClO4)2, at 120K
Authors: Ramazani A. , Morsali A.
Published: September 2014

C24H24Cl2CuN4O12, monoclinic, P121/n1 (No. 14), a = 8.245(2) Å, b = 11.852(2) Å, c = 14.882(3) Å, β = 104.927(4)°, V = 1405.2 Å3, Z = 2, Rgt(F) = 0.051, wRref(F2) = 0.132, T = 120 K.
Crystal structure of 1,2-ethylenediaminesilver(I) bis(4-nitrobenzoato)- silver(I), C16H16Ag2N4O8
Authors: Chen S.-H. , Zhu H.-L. , Pan Y.-J. , Wang X.-J. , Wang D.-Q.
Published: September 2014

C16H16Ag2N4O8, triclinic, P1̅ (No. 2), a = 6.346(3) Å, b = 7.022(3) Å, c = 23.04(1) Å, α = 82.638(7)°, β = 83.169(6)°, ϒ = 67.880(6)°, V = 940.6 Å3, Z = 2, Rgt(F) = 0.031, wRref(F2) = 0.070, T = 298 K.
Crystal structure of diaqua-di(2-methoxyacetato)cobalt(II), C6H14CoO8
Authors: Zhu H.-L. , Zeng Q.-F. , Xia D.-S. , Liu X. , Zhu X.-L. , Wang D.-Q.
Published: September 2014

C6H14CoO8, monoclinic, P121/n1 (No. 14), a = 6.985(1) Å, b = 10.102(2) Å, c = 7.132(1) Å, β = 97.15(1)°, V = 499.3 Å3, Z = 2, Rgt(F) = 0.028, wRref(F2) = 0.072, T = 292 K.
Crystal structure of µ2-hydroxyl-bis(5-methyl-1,4,9-triazanonanezinc(II)) triperchlorate, C14H39Cl3N6O13Zn2
Authors: Zhu H.-L. , Meng F.-J. , Yang F. , Wang Z.-D.
Published: September 2014

C14H39Cl3N6O13Zn2, monoclinic, P121/m1 (No. 11), a = 7.802(2) Å, b = 12.121(3) Å, c = 15.662(3)Å, β = 104.29(2)°, V = 1435.3 Å3, Z=2, Rgt(F) = 0.055, wRref(F2) = 0.152, T = 293 K.
Crystal structure of 4,5-(ethoxyethylenedithio)-1,3-dithiole-2-thione, C7H8OS5
Authors: Xue G. , Yu W.-T. , Fang Q.
Published: September 2014

C7H8OS5, monoclinic, P121/c1 (No. 14), a = 8.3699(7) Å, b = 17.573(2) Å, c = 7.5305(7) Å, β = 103.584(7)°, V = 1076.6 Å3, Z=4, Rgt(F) = 0.033, wRref(F2) = 0.082, T = 293 K.
Crystal structure of meso-dimethyl 2,3-dibenzamido-2,3-dimethylbutanedioate, C22H24N2O6
Authors: Coghlan D. R. , Easton C. J. , Tiekink E. R. T.
Published: September 2014

C22H24N2O6, monoclinic, P121/n1 (No. 14), a = 14.455(3) Å, b = 10.239(2) Å, c = 14.991(5) Å, β = 101.01(2)°, V = 2177.9Å3, Z = 4, Rgt(F) = 0.068, wRref(F2) = 0.244, T = 293 K.
Crystal structure of di[K(18-crown-6)]dirubidium nonagermanide(4–) diethylenediamine, [K(C12H26N2O4)]2Rb2[Ge9] · 2C2N2H8
Authors: Hauptmann R. , Fässler T. F.
Published: September 2014

C28H68Ge9K2N8O8Rb2, monoclinic, P121/c1 (No. 14), a = 16.864(3) Å, b = 12.091(2) Å, c = 26.466(5) Å, β = 97.28(3)°, V = 5353.0Å3, Z = 4, Rgt(F) = 0.058, wRref(F2) = 0.176, T = 153 K.
Crystal structure of trichloro(N-trimethylsilyl)phosphoraniminetrichloroaluminum, [(CH3)3Si(N)PCl3AlCl3]
Authors: Jäschke B. , Jansen M.
Published: September 2014

C3H9AlCl6NPSi, monoclinic, P121/c1 (No. 14), a = 15.541(3) Å, b = 12.615(2) Å, c = 16.210(3) Å, β = 116.128(2)°, V = 2853.3 Å3, Z = 8, Rgt(F) = 0.077, wRref(F2) = 0.231, T = 100 K.
Crystal structure of iron nickel phosphide, Fe1.65Ni1.35P, a Rhabdite extracted from Morasko meteorite
Authors: Moretzki O. , Doering Th. , Geist V. , Morgenroth W. , Wendschuh M.
Published: September 2014

Fe1.65Ni1.35P8, tetragonal, I4̅ (No. 82), a = 9.059(2) Å, c = 4.479(1) Å, V = 367.6 Å3, Z = 8, Rgt(F) = 0.022, wRref(F2) = 0.049, T = 293 K.
Crystal structure of iron nickel phosphide, Fe1.8Ni1.2P, a Schreibersite extracted from Orange River meteorite
Authors: Moretzki O. , Doering Th. , Geist V. , Morgenroth W. , Wendschuh M.
Published: September 2014

Fe1.8Ni1.2P8, tetragonal, I4̅ (No. 82), a = 9.085(5) Å, c = 4.481(3) Å, V = 369.8 Å3, Z = 8, Rgt(F) = 0.037, wRref(F2) = 0.086, T = 293 K.
Crystal structure of barium europium germanide, Ba6-xEuxGe25 (x = 0.6), a chiral clathrate
Authors: Carrillo-Cabrera W. , Cardoso Gil R. , Paschen S. , Grin Yu.
Published: September 2014

Ba5.40Eu0.60Ge25, cubic, P4132 (No. 213), a = 14.5271(2) Å, V = 3065.8 Å3, Z = 4, Rgt(F) = 0.055, wRref(F2) = 0.091, T = 295 K.
Crystal structure of lithium ammonium hexachlorotellurate(IV), [Li0.2(NH4)0.8]2TeCl6
Authors: Karray R. , Kabadou A. , Loukil M. , Salah A. Ben
Published: September 2014

Cl6H6.4Li0.4N1.6Te, cubic, Fm3̅m (No. 225), a = 10.357(2) Å, V = 1111.0 Å3, Z = 4, Rgt(F) = 0.060, wRref(F2) = 0.149, T = 299 K.
Crystal structure of bisacetonitrile-tetracarbonylmolybdenum— acetonitrile solvate, Mo(CO)4(NCCH3)2 · CH3CN
Authors: Biesemeier Frank , Harms Klaus , Müller Ulrich
Published: September 2014

C10H9MoN3O4, monoclinic, C12/c1 (No. 15), a = 12.904(2) Å, b = 12.771(2) Å, c = 9.211(1) Å, β = 116.16(2)°, V = 1362.5 Å3, Z = 4, Rgt(F) = 0.064, wRref(F2) = 0.156, T = 193 K.
Crystal structure of di(2,2′-bipyridine)tetra(μ-3-methoxylbenzoato-O,O′)-di(3-methoxybenzoato)diterbium(III), Tb2(C8H7O3)6(C10H8N2)2
Authors: Li X. , Zou Y.-Q.
Published: September 2014

C68H58N4O18Tb2, monoclinic, P121/c1 (No. 14), a = 10.582(4) Å, b = 16.149(5) Å, c = 18.821(6) Å, β = 100.554(6)°, V = 3161.9 Å3, Z = 2, Rgt(F) = 0.058, wRref(F2) = 0.178, T = 293 K.
Crystal structure of di(1,10-phenanthroline-N,N′)di[μ-(2-furancarboxylato- O,O′)-μ-(2-furancarboxylato-O,O′:O′)]di(nitrato)diterbium(III), Tb2(NO3)2(C5H3O3)4(C12H8N2)2
Authors: Li X. , Zou Y.-Q.
Published: September 2014

C22H14N3O9Tb, triclinic, P1̅ (No. 2), a = 10.383(3) Å, b = 10.512(3) Å, c = 11.001(3) Å, α = 81.201(6)°, β = 88.491(6)°, γ = 67.595(5)°, V = 1096.3 Å3, Z = 2, Rgt(F) = 0.039, wRref(F2) = 0.067, T = 293 K.
Crystal structure of (1R*,2S*,5S*,6S*,7R*)-6-(3,5-dinitrobenzoyloxy)methyl-2,7-dimethyl-tricyclo [5.2.2.01,5]undec-8-ene, C21H24N2O6
Authors: Euler H. , Kirfel A. , Valder C. , Neugebauer M. , Meier M. , Braun N. A.
Published: September 2014

C21H24N2O6, orthorhombic, P212121 (No. 19), a = 6.285(2) Å, b = 9.044(4) Å, c = 35.52(2) Å, V = 2019.0 Å3, Z = 4, R(F) = 0.095, wRref(F2) = 0.279, T = 295 K.
Crystal structure of cis-bis(N,N-dimethyl-N′-4-chlorobenzoylthioureato) palladium(II), Pd(C10H10ClN2OS)2
Authors: Arslan H. , Vanderveer D. , Emen F. , Külcü N.
Published: September 2014

C20H20Cl2N4O2PdS2, monoclinic, P121/c1 (No. 14), a = 12.323(4) Å, b = 8.629(3) Å, c = 21.212(7) Å, β = 97.170(6)°, V = 2238.0 Å3, Z = 4, Rgt(F) = 0.045, wRref(F2) = 0.133, T = 193 K.
Crystal structure of 2-acetonyl-5-benzyl-4,6-dimethoxy-5-nitro-2,5-dihydropyrimidine, C16H19N3O5
Authors: Van Meervelt L. , Uytterhoeven K.
Published: September 2014

C16H19N3O5, monoclinic, P121/c1 (No. 14), a = 12.010(1) Å, b = 11.877(1) Å, c = 12.110(1) Å, β = 95.83(2)°, V = 1718.5 Å3, Z = 4, Rgt(F) = 0.044, wRref(F2) = 0.129, T = 289 K.
Crystal structure of monoaquabenzoato-2,5,8-triaza-1,9-di(2-fluorobenzyl)-nonanecopper(II) benzoate dihydrate, Cu(C25H30F2N3O3)(C7H5O2) · 2H2O
Authors: Zhu H.-L. , Shao S.-C. , Ma J.-L. , Qiu X.-Y. , Yang S. , Sun L.
Published: September 2014

C32H39CuF2N3O7, triclinic, P1̅̅̅ (No. 2), a = 7.331(3) Å, b = 8.983(3) Å, c = 26.34(1) Å, α = 95.570(6)°, β = 95.797(6)°, γ = 110.811(5)°, V = 1596.3 Å3, Z = 2, Rgt(F) = 0.040, wRref(F2) = 0.103, T = 298 K.
Crystal structure of diaqua-dibenzoato-dihexamethylenetetraminenickel(II) dihydrate, Ni(C6H12N4)2(C7H5O2)2(H2O)2 · 2H2O
Authors: Zhu H.-L. , Sun L. , Yang S. , Qiu X.-Y. , Shao S.-C. , Ma J.-L.
Published: September 2014

C26H42N8NiO8, monoclinic, C12/c1 (No. 15), a = 22.784(5) Å, b = 10.886(2) Å, c = 12.208(2) Å, β = 95.50(3)°, V = 3014.0 Å3, Z = 4, Rgt(F) = 0.074, wRref(F2) = 0.156, T = 293 K.
Crystal structure of 4,5-methylenedithio-1,3-dithiol-2-thione, C4H2S5
Authors: Liu Z. , Yu W.-T. , Tao X.-T. , Jiang M.-H.
Published: September 2014

C4H2S5, orthorhombic, Pnma (No. 62), a = 13.015(1) Å, b = 9.193(1) Å, c = 6.151(1) Å, V = 735.9 Å3, Z = 4, Rgt(F) = 0.040, wRref(F2) = 0.118, T = 293 K.
Crystal structure of 13,27-dichloro-29,30-dihydroxy-3,9,17,23-tetramethyl-6,20-dioxa-3,9,17,23-tetraazatri-cyclo[23.3.1.111.15]triaconta- 1(29),11,13,15(30),25,27-hexaene-(aqua)magnesium hydrate, Mg[C28H40Cl2N4O4(H2O)] · H2O
Authors: Nazarenko A. Y. , Dalley N. K. , Bradshaw J. S. , Pastushok V. N. , Lamb J. D.
Published: September 2014

C28H44Cl2MgN4O6, triclinic, P1̅ (No. 2), a = 10.397(3) Å, b = 11.152(3) Å, c = 14.728(5) Å, α = 74.25(2)°, β = 80.51(2)°, γ = 77.00(2)°, V = 1591.6 Å3, Z = 2, Rgt(F) = 0.056, wRref(F2) = 0.174, T = 293 K.
Crystal structure of 4-(4-pyridil)-3,5-dimethylpyrozole hydrate, (C5H4N)CH3(C3N2H)CH3 · H2O
Authors: Li H. , Jin Q.-H , Yu S.-Y. , Ma H.-W. , Li Y.
Published: September 2014

C10H13N3O, triclinic, P1̄ (no. 2), a = 7.475(2) Å, b = 9.171(2) Å, c = 15.536(3) Å, α = 80.88(3)°, β = 89.91(3)°, γ = 81.24(3)°, V = 1039.0 Å3, Z = 4, Rgt(F) = 0.063, wRref(F2) = 0.085, T = 293K.
Crystal structure of dichlorido(N-(biphenyl-2-ylmethyl)-N-(2-ethoxyethyl)]- imidazolidin-2-ylidene(η6-hexamethylbenzene)ruthenium, Ru(C12H18)(C20H24N2O)Cl2
Authors: Arslan H. , Vanderveer D. , Özdemir I. , Cetinkaya B. , Yasar S.
Published: September 2014

C32H42Cl2N2ORu, monoclinic, P121/c1 (no. 14), a = 12.930(4) Å, b = 18.094(6) Å, c = 13.655(4) Å, β = 114.00(2)°, V = 2918.4 Å3, Z = 4, Rgt(F) = 0.046, wRref(F2) = 0.133, T = 193 K.
Crystal structure of (1aSR,5bRS,7aSR,10aRS,10bSR,10cRS)-1a,5b,6,7,7a,8,9, 10,10b,10c-decahydro-10aH-cyclopenta[1,2]phenanthro[9,10-b]oxiren-10a-ol, C17H20O2
Authors: Berndt M. , Brüdgam I. , Hartl H. , Reißig H.-U.
Published: September 2014

C17H20O2, monoclinic, P121/n1 (no. 14), a = 6.618(1) Å, b = 27.538(5) Å, c = 14.951(3) Å, β = 98.768(4)°, V = 2692.8 Å3, Z = 8, Rgt(F) = 0.054, wRref(F2) = 0.150, T = 153 K
Crystal structure of 2-[(2-ethyl)phenylamino]pyridine, C13H14N2
Authors: Talja M. , Polamo M.
Published: September 2014

C13H14N2, monoclinic, P121/c1 (no. 14), a = 11.892(6) Å, b = 7.570(7) Å, c = 13.309(7) Å, β = 112.65(3)°, V = 1105.7 Å3, Z = 4, Rgt(F) = 0.055, wRref(F2) = 0.151, T = 193 K.
Crystal structure of (triphenylphosphine)(pyrrolinedithiocarbamato)- gold(I), (C6H5)3PAu(S2CNC4H8)
Authors: Ho S. Y. , Tiekink E. R. T.
Published: September 2014

C23H23AuNPS2, triclinic, P1̅ (no. 2), a = 8.524(1) Å, b = 9.822(1) Å, c = 13.815(2) Å, α = 73.492(2)°, β = 86.641(2)°, γ = 88.638(2)°, V = 1107.1 Å3, Z = 2, Rgt(F) = 0.036, wRref(F2) = 0.091, T = 183 K.
Crystal structure of di(tetramethylammonium)tetrachloropalladate(II), [N(CH3)4]2[PdCl4]
Authors: Heines P. , Keller H.-L.
Published: September 2014

C8H24Cl4N2Pd, tetragonal, P42/mnm (no. 136), a = 8.8287(2) Å, c = 11.4264(3) Å, V = 890.6 Å3, Z = 2, Rgt(F) = 0.024, wRref(F2) = 0.072, T = 293 K.
Crystal structure of tin(II) acetate acetylacetonate, Sn(C5H7O2)(C2H3O2)
Authors: Reuter H.
Published: September 2014

C7H10O4Sn, monoclinic, C12/c1 (no. 15), a = 12.459(3) Å, b = 9.676(2) Å, c = 16.237(3) Å, β = 99.55(2)°, V = 1930.3 Å3, Z = 8, Rgt(F) = 0.032, wRref(F2) = 0.084, T = 293 K.
Crystal structure of 1,2,6,7,11,12-hexathia-cyclopentadecane, C9H18S6
Authors: Sun Y.-Q. , Sun J. , Guo Y.-W.
Published: September 2014

C9H18S6, triclinic, P1̅ (no. 2), a = 5.637(1) Å, b = 14.748(4) Å, c = 17.913(4) Å, α= 86.663(5)°, β = 82.988(4)°, γ = 83.742(4)°, V = 1467.7 Å3, Z = 4, Rgt(F) = 0.072, wRref(F2) = 0.166, T = 293 K.
Crystal structure of [N,N-bis(2-[2-pyridyl]ethyl)-2-(2-aminoethoxy)ethanol]- copper(II) bis(trifluoromethanesulfonate), (CuC18H25N3O2)(F3CSO3)2
Authors: Selmeczi K. , Speier G. , Réglier M. , Giorgi M.
Published: September 2014

C20H25CuF6N3O8S2, triclinic, P1̅ (no. 2), a = 8.0561(4) Å, b = 11.766(1) Å, c = 14.859(1) Å, α = 75.539(3)°, β = 84.980(5)°, γ = 82.435(5)°, V = 1349.8 Å3, Z = 2, Rgt(F) = 0.068, wRref(F2) = 0.135, T = 293 K.
Crystal structure of bis(2-aminopyrimidine)silver(I) hexafluoroarsenate bis(2-aminopyrimidine) solvate, [Ag(C4H5N3)2]AsF6 · 2C4H5N3
Authors: Yang H.-L. , Yang S. , Qiu X.-Y. , Shao S.-C. , Ma J.-L. , Sun L. , Zhu H.-L.
Published: September 2014

C16H20AgAsF6N12, triclinic, P1̅ (no. 2), a = 7.004(1) Å, b = 8.696(2) Å, c = 11.006(2) Å, α = 68.95(3)°, β = 76.49(3)°, γ = 81.90(3)°, V = 607.1 Å3, Z = 1, Rgt(F) = 0.044, wRref(F2) = 0.111, T = 293 K.
Crystal structure of bis[N,N′-bis(2-fluorobenzylidene)ethylenediamine]silver( I) 4-chlorobenzoate 4-chlorobenzoic acid, Ag(C16H14N2F2)2(C14H9O2Cl2)
Authors: Ma J.-L. , Yang L. , Chen B. , Zou Y. , Meng F.-J. , Zhu H.-L.
Published: September 2014

C46H37AgCl2F4N4O4, orthorhombic, Pccn (no. 56), a = 27.93(1) Å, b = 7.208(3) Å, c = 21.083(8) Å, V = 4244.0 Å3, Z = 4, Rgt(F) = 0.035, wRref(F2) = 0.069, T = 298 K.
Crystal structure of bis[di(1,10-phenanthroline)azidocopper(II)] biphenyl- 4,4′-dicarboxylate pentahydrate, [Cu(C12H8N2)2N3]2(C14H8O4) · 5H2O
Authors: Ye M.-D. , Cheng Y.-Q. , Li X.-H. , Hu M.-L.
Published: September 2014

C62H50Cu2N14O9, monoclinic, P12/n1 (no. 13), a = 15.7454(6) Å, b = 7.9119(3) Å, c = 22.3267(9) Å, β = 96.150(2)°, V = 2765.4 Å3, Z = 2, Rgt(F) = 0.071, wRref(F2) = 0.144, T = 293 K.
Crystal structure of dimethyl (Z)-2(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)- 2-butenedioate, C14H11NO6
Authors: Ramazani A. , Marandi F. , Ahmadi E. , Morsali A.
Published: September 2014

C14H11NO6, monoclinic, P121/n1 (no. 14), a = 8.068(2) Å, b = 9.679(2) Å, c = 16.961(3) Å, β = 101.69(3)°, V = 1297.1 Å3, Z = 4, Rgt(F) = 0.076, wRref(F2) = 0.160, T = 120 K.
Crystal structure of diethyl 2-(dibenzoylmethyl)-3-(triphenylphosphoranylidene) succinate, C41H37O6P
Authors: Ramazani A. , Dolatyari L. , Kazemizadeh A. R. , Ahmad E. , Torabi A. A. , Welter R.
Published: September 2014

C41H37O6P, triclinic, P1̅ (no. 2), a = 11.128(5) Å, b = 12.548(5) Å, c = 13.420(5) Å, α = 87.523(5)°, β = 84.819(5)°, γ = 64.188(5)°, V = 1680.0 Å3, Z = 2, Rgt(F) = 0.058, wRref(F2) = 0.148, T = 173 K.
Crystal structure of methyl-2-hydroxy-2-phenyl-3-(4-bromophenyl)-3- phenylamino-propanoate, C22H20BrNO3
Authors: Malpezzi L.
Published: September 2014

C22H20BrNO3, monoclinic, P121/c1 (no. 14), a = 17.643(1) Å, b = 5.935(1) Å, c = 18.782(1) Å, β = 90.13(1)°, V = 1966.7 Å3, Z = 4, Rgt(F) = 0.041, wRref(F2) = 0.117, T = 293 K.
Crystal structure of pentalanthanum trilead monoiodide, La5Pb3I
Authors: Mattausch Hj. , Simon A. , Zheng C.
Published: September 2014

ILa5Pb3, hexagonal, P63/mcm (no. 193), a = 9.736(1) Å, c = 6.947(1) Å, V = 570.3 Å3, Z = 2, Rgt(F) = 0.029, wRref(F2) = 0.068, T = 293 K.
Crystal structures of cobalt aluminum silicide, Co19+xAl43+ySi12-y (x = -0.14, y = 0.14; x = 0.49, y = -0.49), the ϒ phase in the Co-Al-Si system
Authors: Richter K. W. , Prots Yu.
Published: September 2014

Al43.14Co18.86Si11.86, monoclinic, C12/c1 (no. 15), a = 20.010(2) Å, b = 19.1498(7) Å, c = 12.8227(8) Å, β = 123.56(1)°, V = 4094.6 Å3, Z = 4, Rgt(F) = 0.035, wRref(F2) = 0.079, T = 293 K.

Al42.51Co19.49Si12.49, monoclinic, C12/c1 (no. 15), a = 20.025(2) Å, b = 19.173(2) Å, c = 12.835(1) Å, β = 123.63(1)°, V = 4103.2 Å3, Z = 4, Rgt(F) = 0.044, wRref(F2) = 0.108, T = 293 K.
Crystal structure of nonasilver hexathioaluminate, Ag9AlS6, the ϒ phase
Authors: Zaiss T. , Deiseroth H.-J.
Published: September 2014

Ag9AlS6, cubic, F4̅3m (no. 216), a = 10.739(1) Å, V = 1238.5 Å3, Z = 4, Rgt(F) = 0.034, wRref(F2) = 0.049, T = 293 K.
Crystal structure of hexaaquamagnesium diammonium hexathiodiphosphate( IV) dihydrate, [Mg(H2O)6](NH4)2[P2S6] · 2H2O
Authors: Hinrichs F. , Gjikaj M.
Published: September 2014

H24MgN2O8P2S6, monoclinic, P121/c1 (no. 14), a = 10.961(2) Å, b = 6.8664(6) Å, c = 12.981(2) Å, β = 111.19(1)°, V = 910.9 Å3, Z = 2, Rgt(F) = 0.027, wRref(F2) = 0.064, T = 223 K.
Crystal structure of μ3-chloro-μ3-hydroxo-tris(μ-chloro)tris(tetramethylethylenediamine) trinickel(II) triiodide, [Ni3(C6H16N2)3Cl4(OH)][I3]
Authors: Miyamoto K. , Horn E. , Fukuda Y.
Published: September 2014

C18H49Cl4I3N6Ni3O, triclinic, P1̅ (no. 2), a = 15.371(3) Å, b = 11.777(2) Å, c = 11.505(2) Å, α = 96.075(7)°, β = 84.816(6)°, ϒ = 111.562(6)°, V = 1923.1 Å3, Z = 2, Rgt(F) = 0.061, wRref(F) = 0.065, T = 273 K.
Crystal structure of 3S,4S,5R,6S,7R-5-amino-6-(tert-butyldimethylsiloxy)-7- (tert-butyldimethylsiloxymethyl)-3-hydroxymethyl-2,2-dimethyloxepan-4-ol, C22H49NO5Si2
Authors: Al-Harrasi A. , Brüdgam I. , Hartl H. , Reißig H.-U.
Published: September 2014

C22H49NO5Si2, monoclinic, P1211 (no. 4), a = 10.529(2) Å, b = 8.152(1) Å, c = 16.554(3) Å, β = 98.015(4)°, V = 1406.9Å3, Z = 2, Rgt(F) = 0.064, wRref(F2) = 0.188, T = 173 K.
Crystal structure of dimethyl (2E)-2-[(tert-butylamino)(1,3-dimethyl- 2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)methyl]but-2-enedioate, C17H23N3O7
Authors: Zonouzi A. , Rahmani H. , Samareh Afsari H.
Published: September 2014

C17H23N3O7, monoclinic, P121/c1 (no. 14), a = 15.231(3) Å, b = 15.641(3) Å, c = 7.800(2) Å, β = 97.53(3)°, V = 1842.2 Å3, Z = 4, Rgt(F) = 0.040, wRref(F2) = 0.115, T = 193 K.
Crystal structures of tetrabutylammonium bis(phthalocyaninato)terbium(III) methanol solvate hydrate (1:1: 3/2), [N(C4H9)4][Tb(C8H4N2)2]·CH3OH· 3/2 H2O, and tetrabutylammonium bis(phthalocyaninato)dysprosium(III) methanol solvate hydrate (1:1:1), [N(C4H9)4][Dy(C8H4N2)2]·CH3OH·H2O
Authors: Loosli C. , Liu S.-X. , Neels A. , Labat G. , Decurtins S.
Published: September 2014

C81H75N17O2.50Tb, orthorhombic, Pna21 (no. 33), a = 25.296(2) Å, b = 25.021(2) Å, c = 11.510(1) Å, V = 7285.0 Å3, Z = 4, Rgt(F) = 0.052, wRref(F2) = 0.149, T = 153 K.

C81H74DyN17O2, orthorhombic, Pna21 (no. 33), a = 25.216(2) Å, b = 25.039(2) Å, c = 11.4858(7) Å, V = 7252.0 Å3, Z = 4, Rgt(F) = 0.052, wRref(F2) = 0.090, T = 153 K.
Crystal structure of 6-(carboxymethyl)-2,3,4-trimethoxybenzoic acid, C12H14O7
Authors: Khan G. S. , Rama N. H. , Noor A. , Qadeer G.
Published: September 2014

C12H14O7, orthorhombic, Pbca (no. 61), a = 17.62(1) Å, b = 7.040(4) Å, c = 20.51(1) Å, V = 2544.2 Å3, Z = 8, Rgt(F) = 0.041, wRref(F2) = 0.099, T = 293 K.
Crystal structure of potassium rubidium bis(L-malate) L-malic acid, K(K0.67Rb0.33)(C4H5O5)2 · C4H6O5
Authors: Rodrigues V. H. , Costa M. M. R. , Matos Gomes E. , Criado A.
Published: September 2014

C12H16K1.67O15Rb0.33, orthorhombic, P212121 (no. 19), a = 7.721(1) Å, b = 7.895(2) Å, c = 29.914(3) Å, V = 1823.6Å3, Z = 4, Rgt(F) = 0.061, wRref(F2) = 0.147, T = 293 K.
Crystal structure of bis(acetylacetonato)bis(quinoline)nickel(II), Ni(C5H14O2N)2(C9H7N)2
Authors: Zukerman-Schpector J. , Caracelli I. , Trindade A. C. , Cussigh O. , Dunstan P. O.
Published: September 2014

C28H28N2NiO4, triclinic, P1̅ (no. 2), a = 7.9202(6) Å, b = 8.0496(6) Å, c = 10.246(1) Å, α = 97.15(1)°, β = 106.68(1)°, ϒ = 94.686(9)°, V = 616.1 Å3, Z = 1, Rgt(F) = 0.028, wRref(F2) = 0.078, T = 293 K.
Crystal structure of N-phenyl-3-[2-(4'-chlorophenylthio)propanoyl]-2- azetidinone, C18H16ClNO2S
Authors: Zukerman-Schpector J. , Domingues N. L. C. , Olivato P. R. , Mondino M. G. , Reis A. K. C. A. , Rittner R. , Lima F. S.
Published: September 2014

C18H16ClNO2S, monoclinic, P121/c1 (no. 14), a = 10.211(1) Å, b = 6.5258(9) Å, c = 24.334(3) Å, β = 90.279(9)°, V = 1621.5 Å3, Z = 4, Rgt(F) = 0.044, wRref(F2) = 0.112, T = 293 K.
Crystal structure of ethyl 1-[(2'-cyanobiphenyl-4-yl)methyl]- 2-ethoxybenzimidazole-7-carboxylate, C26H23N3O3
Authors: Li T.-H. , Mao X.-B. , Song Q.-B.
Published: September 2014

C26H23N3O3, monoclinic, P121/n1 (no. 14), a = 11.480(1) Å, b = 8.377(1) Å, c = 22.824(3) Å, β = 90.299(3)°, V = 2195.0 Å3, Z = 4, Rgt(F) = 0.051, wRref(F2) = 0.111, T = 293 K.
Crystal structure of ethyl 3,5-dihydroxybenzoate hemihydrate, C9H10O4 · ½H2O
Authors: Zhang Q.-W. , Wang G.-X.
Published: September 2014

C9H11O4.5, monoclinic, P121/c1 (no. 14), a = 7.353(2) Å, b = 14.523(3) Å, c = 17.585(4) Å, β = 93.387(3)°, V = 1874.7 Å3, Z = 8, Rgt(F) = 0.040, wRref(F2) = 0.092, T = 273 K.
Crystal structure of pyridinium tetrahydroxyhexaoxopentaborate pyridine hemisolvate, (C5H6N)[B5O6(OH)4] · ½C5H5N
Authors: Zhang W.-J. , Liu Z.-H.
Published: September 2014

C7.5H12.5B5N1.5O10, monoclinic, C12/c1 (no. 15), a = 15.49(1) Å, b = 11.554(7) Å, c = 17.81(1) Å, β = 110.478(9)°, V = 2985.3 Å3, Z = 8, Rgt(F) = 0.055, wRref(F2) = 0.179, T = 298 K.
Crystal structure of 2-nitrobenzene-1,4-dioxyacetic acid dihydrate, C6H3(NO2)(OCH2COOH)2 · 2H2O
Authors: Yu W. , Zhang T.-L. , Yang L. , Zhang J.-G. , Wu R.-F. , Ren F.-J. , Guo J.-Y. , Liu L.-H.
Published: September 2014

C10H13NO10, monoclinic, P121/n1 (no. 14), a = 7.351(2) Å, b = 22.077(5) Å, c = 8.129(2) Å, β = 99.907(4)°, V = 1299.5 Å3, Z = 4, Rgt(F) = 0.041, wRref(F2) = 0.106, T = 294 K.
Crystal structure of chloro(acrylato-O,O')bis(1,10-phenanthroline-N,N')- cadmium(II), CdCl(C3H3O2)(C12H8N2)2
Authors: Cai T.-J. , Jiang W.-J. , Peng Z.-S. , Long Y.-F. , Deng Q.
Published: September 2014

C27H19CdClN4O2, triclinic, P1̅ (no. 2), a = 9.485(3) Å, b = 10.650(3) Å, c = 13.167(4) Å, α = 80.904(7)°, β = 85.256(7)°, ϒ = 66.161(6)°, V = 1201.0 Å3, Z = 2, Rgt(F) = 0.024, wRref(F2) = 0.060, T = 273 K.
Crystal structure of dicalcium sodium monohydrogen diarsenate hexahydrate, Ca2Na[HAsO4][AsO4] · 6H2O
Authors: Jiménez A. , Rodríguez J. D. , Torre-Fernández L. , Prieto M. , García-Granda S.
Published: September 2014

As2Ca2H13NaO14, triclinic, P1̅ (no. 2), a = 6.680(5) Å, b = 8.223(4) Å, c = 12.537(3) Å, α = 73.46(5)°, β = 78.89(4)°, γ = 87.47(5)°, V = 647.7 Å3, Z = 2, Rgt(F) = 0.062, wRref(F2) = 0.197, T = 293 K.